Press Release | Newsroom | Medtronic | Covidien to Present at Raymond James 35th Annual Institutional Investors Conference

Press Release

Printer Friendly Version View printer-friendly version
<< Back
Covidien to Present at Raymond James 35th Annual Institutional Investors Conference

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 24, 2014-- Covidien plc (NYSE: COV) will present at the Raymond James 35th Annual Institutional Investors Conference in Orlando, Fla., on March 3. Charles J. Dockendorff, executive vice president and chief financial officer, will discuss the company in a presentation scheduled to begin at 9:50 a.m. ET.

A live audio webcast of the presentation can be accessed at Covidien’s Investor Relations website: http://investor.covidien.com. An archived edition of the presentation will be available following the live webcast.

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien develops, manufactures and sells a diverse range of industry-leading medical device and supply products. With 2013 revenue of $10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are sold in over 150 countries. Please visit www.covidien.com to learn more about our business.

Source: Covidien plc

Covidien plc
Peter Lucht, 508-452-4168
Vice President
External Communications
peter.lucht@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Lisa Clemence, 508-452-4375
Director
Corporate Communications
lisa.clemence@covidien.com
or
Todd Carpenter, 508-452-4363
Senior Director
Investor Relations
todd.carpenter@covidien.com

X